Pharmidex In Silico Drug Discovery Step 5 Pharmacophore Modeling
February 27, 2025

Pharmidex continues to drive innovation in computational drug discovery! Following Molecular Docking, our Pharmacophore Modeling step refines drug design by identifying key molecular features essential for target binding, enhancing lead optimization.


✨ Why is this step crucial?

✅ Defines essential chemical and spatial features for drug activity

✅ AI-driven modeling for precise hit identification

✅ Optimizes drug-target interactions for enhanced efficacy

✅ Seamlessly integrates with our in silico pipeline for accelerated discovery


With advanced computational tools and scientific expertise, we de-risk drug development and accelerate therapeutic breakthroughs.


📽️ Watch our latest video (4/5) to see how Pharmacophore Modeling refines drug design!


📩 Let’s collaborate to advance drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #PharmacophoreModeling #PharmaceuticalInnovation

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts